<?xml version="1.0" encoding="utf-8" standalone="yes"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>ASGCT on Peter Boone</title>
    <link>https://boonepeter.github.io/tags/asgct/</link>
    <description>Recent content in ASGCT on Peter Boone</description>
    <generator>Hugo -- gohugo.io</generator>
    <lastBuildDate>Sat, 16 Nov 2019 00:00:00 +0000</lastBuildDate><atom:link href="https://boonepeter.github.io/tags/asgct/index.xml" rel="self" type="application/rss+xml" />
    <item>
      <title>ASGCT Policy Summit, Day 3</title>
      <link>https://boonepeter.github.io/posts/2019-11-16-asgct-gene-editing-ethics-post/</link>
      <pubDate>Sat, 16 Nov 2019 00:00:00 +0000</pubDate>
      
      <guid>https://boonepeter.github.io/posts/2019-11-16-asgct-gene-editing-ethics-post/</guid>
      <description>Washington, DC - Nov. 6, 2019
The American Society of Gene and Cell Therapy held a 3 day summit to discuss policy and other issues around gene editing and gene therapy.
Day 1 addressed regulatory issues in gene therapy development Day 2 dealt with payment policies around gene therapy Day 3 (the day I attended) was focused on the ethical, societal, and policy issues around germline gene editing Links to some of the presentations can be found on ASGCT&amp;rsquo;s website.</description>
    </item>
    
  </channel>
</rss>
